We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
-13.01%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.49B
AUM Growth
-$509M
Cap. Flow
-$84.1M
Cap. Flow %
-3.37%
Top 10 Hldgs %
14.83%
Holding
445
New
32
Increased
164
Reduced
186
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 16.18%
3 Industrials 12.08%
4 Healthcare 11.93%
5 Consumer Discretionary 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
376
Xenon Pharmaceuticals
XENE
$6.12B
$654K 0.03%
+21,508
New +$650K
CRDF icon
377
Cardiff Oncology
CRDF
$77.2M
$652K 0.03%
296,507
+215,514
+266% +$361K
DAR icon
378
Darling Ingredients
DAR
$9.44B
$639K 0.03%
10,686
+15
+0.1% +$1.14K
CNTY icon
379
Century Casinos
CNTY
$34M
$633K 0.03%
87,938
+2,195
+3% +$20.5K
ALT icon
380
Altimmune
ALT
$599M
$624K 0.03%
+53,294
New +$329K
ARGX icon
381
argenx
ARGX
$54.1B
$594K 0.02%
+1,569
New +$505K
ABNB icon
382
Airbnb
ABNB
$107B
$582K 0.02%
6,531
ATRC icon
383
AtriCure
ATRC
$2.11B
$578K 0.02%
14,144
+353
+3% +$16.7K
PHAT icon
384
Phathom Pharmaceuticals
PHAT
$692M
$576K 0.02%
68,236
+37,646
+123% +$387K
EQT icon
385
EQT Corp
EQT
$32.3B
$565K 0.02%
+16,418
New +$677K
TEX icon
386
Terex
TEX
$7.74B
$535K 0.02%
19,553
-12,919
-40% -$430K
CLR
387
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$525K 0.02%
+8,036
New +$509K
IOVA icon
388
Iovance Biotherapeutics
IOVA
$2.87B
$497K 0.02%
+45,037
New +$590K
IVV icon
389
iShares Core S&P 500 ETF
IVV
$904B
$488K 0.02%
1,286
HBI
390
DELISTED
Hanesbrands
HBI
$473K 0.02%
45,936
-70,609
-61% -$877K
RARE icon
391
Ultragenyx Pharmaceutical
RARE
$2.55B
$439K 0.02%
+7,355
New +$453K
TER icon
392
Teradyne
TER
$59.3B
$439K 0.02%
4,902
+10
+0.2% +$1.04K
AGG icon
393
iShares Core US Aggregate Bond ETF
AGG
$138B
$414K 0.02%
4,070
IGSB icon
394
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$409K 0.02%
8,100
-2,750
-25% -$140K
SGEN
395
DELISTED
Seagen Inc. Common Stock
SGEN
$408K 0.02%
+2,308
New +$333K
STE icon
396
Steris
STE
$23.1B
$397K 0.02%
1,922
+3
+0.2% +$676
SLQD icon
397
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$383K 0.02%
7,910
DXCM icon
398
DexCom
DXCM
$32B
$361K 0.01%
4,851
+19
+0.4% +$1.73K
GIS icon
399
General Mills
GIS
$19.7B
$357K 0.01%
4,733
+953
+25% +$66.8K
AFMD
400
DELISTED
Affimed
AFMD
$353K 0.01%
12,754
+5,786
+83% +$198K

Similar funds

Chartwell Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Chartwell Investment Partners held 445 positions worth $2.49B, down 17% from $3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Chartwell Investment Partners withdrew a net $84.1M in Q2 2022, closing 33 positions and reducing 186 holdings. Its most notable exit was Southwest Gas, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in TXNM Energy Inc worth $14.9M.

  • Chartwell Investment Partners's largest Q2 2022 buy was TXNM Energy Inc: 311,138 shares worth $14.9M.
  • Chartwell Investment Partners added most to Healthcare Realty in Q2 2022, an estimated $10M increase.
  • Chartwell Investment Partners's biggest Q2 2022 reduction was Foot Locker, cutting an estimated $11M.
  • Chartwell Investment Partners fully exited Southwest Gas in Q2 2022, selling an estimated $10.4M.
  • Chartwell Investment Partners's ten largest holdings make up 15% of its $2.49B portfolio in Q2 2022.
  • Chartwell Investment Partners opened 32 new positions and closed 33 in Q2 2022.
  • Chartwell Investment Partners's portfolio value fell 17% quarter-over-quarter to $2.49B.

Based on Chartwell Investment Partners's 13F filing for Q2 2022, filed 1 Aug 2022.